Read More 2 minute read Pharma Industry News Novartis’ Sandoz gains EC approval for biosimilar Hyrimoz across multiple therapeutic areas In a significant advancement for biopharmaceuticals, Novartis’ division Sandoz has secured approval from the European Commission (EC) for… bypharmanewsdailyJuly 29, 2018
